Sarcoma  >>  ontorpacept (PF-07901800)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ontorpacept (PF-07901800) / Pfizer
TTI-621-03, NCT04996004: A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma

Terminated
2
75
US
Ontorpacept (TTI-621), Ontorpacept / SIRPĪ±-IgG1 Fc, Doxorubicin, Adriamycin
Pfizer
Leiomyosarcoma
12/23
12/23

Download Options